IBUS SEMINAR MARCH 9-10, 2018 TECHNOPARK Zürich. Emphasis on high risk lesions with consensus conference PRELIMINARY PROGRAM

Transcription

1 IBUS SEMINAR 2018 Emphasis on high risk lesions with consensus conference MARCH 9-10, 2018 TECHNOPARK Zürich PRELIMINARY PROGRAM A seminar held under the patronage of the Secretariat Office meeting com Congress Organisation info@meeting-com.ch T Scientific board Florian Dammann, Bern / Zürich, Switzerland Rahel Kubik, Baden, Switzerland Alexander Mundiger, Osnabrück, Germany Christoph Rageth, Geneva, Switzerland Christoph Tausch, Zürich, Switzerland, Switzerland Online registration / Conferences & Meetings / 2018

2 Welcome Dear Colleagues, In the name of the organizing committee and the IBUS faculty members, we wish you a very warm welcome to Zürich, and to this IBUS : Advanced Breast Ultrasound course. This program will again demonstrate the top standards in comprehensive breast diagnosis and is designed to circulate actual information concerning the whole scope of breast imaging. It is directed to sonographers (radiologists, gynecologists and surgeons) who accept the importance of having a conclusive diagnosis before any open surgery. You will find yourself in the middle of a rejuvenated area of the city with many new facilities such as cinemas, restaurants, hotels and also a number of shops. The Hardbrücke is the next town trains stop approximately 800 meters from the meeting venue, and from there you can reach downtown by train within a few minutes. KliniK Hirslanden COMMiTTed TO THe HiGHesT standards Klinik Hirslanden is one of Switzerland s leading private hospitals and is part of the Hirslanden Private Hospital Group. Our patient-oriented approach and cutting-edge medicine informed by the latest research shape our day-to-day activities. Hirslanden s interdisciplinary network of experienced medical specialists and the knowledge of our specialised centres of expertise ensure patients receive integrated and comprehensive medical care. Patients can expect professional and personalised assistance provided by our qualified nursing staff. Exceptional comfort, privacy and hotel-style service round off the Hirslanden experience. For more information, please visit After having already met in Zürich for eight IBUS programs in the Technopark and the facilities of the University Hospital of Zürich, we decided again for the Technopark, where teaching, learning and friendship could be best brought together under the one roof. This part of the Technopark was built 25 years ago, and since 1993 hundreds of motivated, future-oriented people have been working within the Technopark site in different fields which include industrial, commercial and service enterprises and also in industry-oriented research teams. The main goal will be to have again a consensus meeting and consensus statements regarding B3 lesions this will (after 2016) be the second official international consensus conference on B3 lesions. We wish you an enjoyable stay in Zürich, and hope that you will benefit from the expert faculty which has come to share their knowledge with you. We thank all the faculty members, sponsors, the European School of Oncology (ESO) and the Swiss Society of Senology who all support this IBUS meeting. Christoph Rageth (Chairman) Local Organizing Committee EXPERTISE YOU CAN TRUST. 3

3 Organisation & Speakers Friday, March 9, 2018, & st day of IBUS 2018 Seminar Saturday, March 10, 2018, & nd day of IBUS 2018 Seminar Venue Technopark Zürich, Technoparkstrasse 1, 8005 Zürich Main speakers Elizabeth A. Morris, MD, FACR, Memorial Sloan Kettering Cancer Center, New York (US) Elizabeth A. M. O Flynn, MBBS, MRCS, FRCR, Consultant Radiologist, St. George s Hospital, London (GB) Scientific board Florian Dammann, Bern / Zürich Rahel Kubik, Baden Alexander Mundiger, Osnabrück (DE) Christoph Rageth, Geneva Christoph Tausch, Zürich Invited speakers Andreas Boss, Zürich Sophie Dellas, Basel Michael Knauer, St. Gallen Claudia Kurtz, Lucerne Caroline Malhaire, Paris (FR) Martin Sonnenschein, Bern Seminar language English General information Congress office meeting com Congress Organisation Rue des Pâquis Cheseaux-sur-Lausanne T + 41 (0) F +41 (0) E info@meeting-com.ch Online registration / Conferences & Meetings Registration fees Until From early bird & onsite 2 Days 9 & CHF CHF & SSS members CHF CHF & residents* CHF CHF Day CHF CHF CHF CHF Residents CHF CHF CHF CHF * In order to benefit from the reduced fee for residents, you are required to send a document of your employer to the Seminar Secretariat by fax ( ) or scanned (inscriptions@meeting-com.ch) within 7 days from the date of application. The registration fee includes : access to the scientific sessions, certificate of participation, coffee-breaks and lunches. Payment / Confirmation Upon registration you will receive a written confirmation together with the banking details for the payment. Cancellation In case of cancellation 30 days prior the event, the refund of the amount paid will be done net of CHF for administrative costs. Thereafter, no refund possible. Any registration made within the early bird time must be paid during this period. It not the case, the invoice is automatically updated at the current price. Administrative costs will be charged to no shows. Legal jurisdiction is Lausanne. Accreditation In demand to the following societies : Swiss Society for Gynaecology and Obstetrics Swiss Society of Radiology Swiss Society of Pathology Swiss Society of Surgery 4 5

4 Friday March 9, 2018 Friday March 9, 2018 IBUS 2018 Emphasis on high risk lesions with consensus conference Welcome Scientific Board New developments in ultrasound imaging Andreas Boss, Zürich The new BI-RADS : what has changed & why Elizabeth A. Morris, New York (US) Imaging of recurrence (all modalities) Florian Dammann, Bern / Zürich Detection of lymphnodes Martin Sonnenschein, Bern Needle biopsy of lymphnodes when (after the Z0011 trial) and how Michael Knauer, St. Gallen How to manage the axilla initially N+ and clinically negative after neoadjuvant chemotherapy - the radiologists view Sophie Dellas, Basel How to manage the axilla initially N+ and clinically negative after neoadjuvant chemotherapy - the surgeons view Christoph Tausch, Zürich Discussion Coffee break Breast density : assessment and clinical implications Elizabeth A. M. O Flynn, London (GB) The dense breast : how to image Elizabeth A. Morris, New York (US) Comments on dense breast imaging Andreas Boss, Zürich Comments on dense breast imaging Martin Sonnenschein, Bern Intraoperative ultrasound and integration of ultrasound into surgical practice Michael Knauer, St. Gallen Comments on intraoperative ultrasound Christoph Tausch, Zürich Comments on CEM Elizabeth A. Morris, New York (US) Tomosynthesis : ethical not to perform? Elizabeth A. Morris, New York (US) Tomosynthesis new technical considerations Claudia Kurtz, Lucerne Discussion Lunch break New developments in MR imaging Non mass like enhancement in MRI Rahel Kubik, Baden Comments on non mass like enhancement in MRI Second look Ultrasound after suspicious MR Sophie Dellas, Basel Comments on second look Ultrasound after suspicious MR Discussion 6 7

5 Friday March 9, 2018 Saturday March 10, DCIS imaging Claudia Kurtz, Lucerne Ultrasound imaging of DCIS - update of new insights Alexander Mundinger, Osnabrück (DE) DCIS pathology (pathological aspects of margins and size) BI-RADS 3 - scourge of screening? Elizabeth A. Morris, New York (US) Review on pathological estimation of size and margins of DCIS in surgical specimens Elizabeth A. Morris, New York (US) DCIS surgery (margins, surgery vs. observation) Michael Knauer, St. Gallen High incidence of DCIS in screening - high risk of overdiagnosis? Discussion Evolution of benign breast lesions under neoadjuvant chemotherapy for breast cancer and the difficulty to manage multiple breast additional lesions at MR staging of breast cancer before NAC Caroline Malhaire, Paris (FR) Can MRI predict reponsiveness of breast cancer to neoadjuvant therapy? Coffee break MRI as a problem solving tool a critical assessment of the evidence Multimodal ultrasound - where do we stand? Alexander Mundinger, Osnabrück (DE) Addition of ultrasound to mammographic screening Florian Dammann, Bern / Zürich Elastography Claudia Kurtz, Lucerne IBUS 2018 Emphasis on high risk lesions with consensus conference Does ABUS have a role in preoperative staging? Alexander Mundinger, Osnabrück (DE) New clinical decision rules to avoid MRI-guided biopsies Indications of preoperative MRI : what are the best Elizabeth A. M. O Flynn, London (GB) Advanced functional MRI techniques Elizabeth A. M. O Flynn, London (GB) Discussion Deep learning : artificial intelligence for mammography assessment Andreas Boss, Zürich Breast implant associated anaplastic large cell lymphoma Caroline Malhaire, Paris (FR) Can we avoid surgery after neoadjuvant chemotherapy? Christoph Tausch, Zürich Discussion MIBB database (VAB s in Switzerland) update Christoph Rageth, Geneva Risk lesions in minimally invasive biopsies: same pathological results different management Martin Sonnenschein, Bern Coffee break Introduction to the voting system and introductory questions Christoph Rageth, Geneva Wrap up of the newest literature in lobular neoplasia Consensus finding Wrap up of the newest literature in flat epithelial atypia Consensus finding Lunch break 8 9

6 Saturday March 10, 2018 Kind thanks to our sponsors Wrap up of the newest literature in Phyllodes tumors Consensus finding Wrap up of the newest literature in papillomas Consensus finding Wrap up of the newest literature in radial scars Consensus finding Wrap up of the newest literature in atypical ductal hyperplasia cases of ADH in CNB and VAB - experience of the Zurich breast center Christoph Rageth, Geneva Discussion Consensus finding Take home message & Farewell Scientific Board END OF IBUS SEMINAR 2018 & handout of certificates of attendance 10 11

7 Registration form IBUS SEMINAR 2018 To be faxed or mailed back to meeting.com Sàrl Rue des Pâquis Cheseaux-sur-Lausanne Fax +41 (0) Tel. +41 (0) info@meeting-com.ch Registration and payment online through Title (Prof., Dr, Mrs, Mr ) Family name First name Institution Street / Adresse Postal Code City Country Registration fees Until From early bird & onsite 2 Days 9 & CHF CHF & SSS members CHF CHF & residents* CHF CHF Day CHF CHF CHF CHF Residents CHF CHF CHF CHF * In order to benefit from the reduced fee for residents, you are required to send a document of your employer to the Seminar Secretariat by fax ( ) or scanned (inscriptions@meeting-com.ch) within 7 days from the date of application. The registration fee includes : access to the scientific sessions, certificate of participation, coffee-breaks and lunches. Seminar Language English Payment / Confirmation Upon registration you will receive a written confirmation together with the banking details for the payment. Cancellation In case of cancellation 30 days prior the event, the refund of the amount paid will be done net of CHF for administrative costs. Thereafter, no refund possible. Any registration made within the «early bird» time must be paid during this period. It not the case, the invoice is automatically updated at the current price. Administrative costs will be charged to no shows. Legal jurisdiction is Lausanne. 12